Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2007-06-13Clinical Trial Update: Comparison of Intramuscular Olanzapine and Intramuscular Haloperidol in Patients With Schizophrenia [Phase 3]
A Phase 3 clinical trial comparing intramuscular olanzapine with intramuscular haloperidol in schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2007-06-13Clinical Trial Update: Managing Acute Schizophrenia, a Comparison Between Two Atypical Antipsychotics [Phase 4]
Phase 4 trial comparing two atypical antipsychotics for acute schizophrenia has completed, with results reported. The document provides a su…
-
CLINICAL_TRIALS trial_result · 2007-06-13Clinical Trial Update: Examining Rapid Acting Intra-Muscular Olanzapine in Japanese Patients With Schizophrenia [Phase 1, Phase 2]
Phase 1/2 clinical trial update evaluating rapid-acting intramuscular olanzapine in Japanese patients with schizophrenia.
-
CLINICAL_TRIALS trial_result · 2007-06-13Clinical Trial Update: Weight Gain Management in Patients With Schizophrenia [Phase 4]
A Phase 4 clinical trial update from Eli Lilly on weight gain management in patients with schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2007-06-13Clinical Trial Update: Assessment of a Weight Management Program for Weight Gain in Patients With Schizophrenia [Phase 4]
Phase 4 clinical trial update evaluating a weight management program to mitigate weight gain in patients with schizophrenia; the study has c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2007-06-12Clinical Trial Update: Olanzapine Versus Placebo in the Treatment of Adolescents With Schizophrenia [Phase 3]
Phase 3 clinical trial update comparing olanzapine to placebo in adolescents with schizophrenia, sponsored by Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2007-06-12Clinical Trial Update: Comparison of Intramuscular Olanzapine Depot With Placebo in the Treatment of Patients With Schizophrenia [Phase 3]
A Phase 3 trial comparing intramuscular olanzapine depot with placebo in schizophrenia has completed, sponsored by Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2007-06-08Clinical Trial Update: A Study Using Rapid Acting Intramuscular Olanzapine in Agitated Patients With Schizophrenia [Phase 2]
Phase 2 study evaluating rapid-acting intramuscular olanzapine for agitation in patients with schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2007-05-03Clinical Trial Update: The Efficacy of Escitalopram for Negative Symptoms in Schizophrenia [Phase 3]
Phase 3 trial update evaluating the efficacy of escitalopram for negative symptoms in schizophrenia.
-
CLINICAL_TRIALS trial_result · 2007-05-02Clinical Trial Update: The Monitor of Serum Prolactin Level in a 3 Months Aripiprazole Trial [Phase 4]
Phase 4 trial update evaluating aripiprazole with a focus on monitoring serum prolactin levels over 3 months in schizophrenia and related co…
-
CLINICAL_TRIALS trial_result · 2007-04-23Clinical Trial Update: The Use of Selective Estrogen Receptor Modulators in the Treatment of Schizophrenia- a Pilot Study [Phase 2]
A Phase 2 pilot study evaluating selective estrogen receptor modulators for schizophrenia and related psychotic disorders has completed.
-
CLINICAL_TRIALS trial_result · 2007-04-19Clinical Trial Update: Effect of Switch to Aripiprazole on Health and Smoking Parameters in Patients With Schizophrenia: A Pilot Study [Phase 4]
Phase 4 pilot study examining the effects of switching to aripiprazole on health and smoking parameters in patients with schizophrenia.
-
CLINICAL_TRIALS trial_result · 2007-03-22Clinical Trial Update: Antipsychotic and Motor Effects of ACP-103 When Administered in Combination With Haloperidol and Risperidone [Phase 2]
This Phase 2 study in schizophrenia evaluated ACP-103 in combination with haloperidol and risperidone and has completed, focusing on antipsy…
-
CLINICAL_TRIALS trial_result · 2007-01-29Clinical Trial Update: Aripiprazole for the Treatment of Schizophrenia With Co-Morbid Social Anxiety [Phase 4]
Phase 4 trial of aripiprazole for schizophrenia with co-morbid social anxiety completed.
-
CLINICAL_TRIALS trial_result · 2007-01-26Clinical Trial Update: Efficacy of High Dose Olanzapine for the Treatment of Schizophrenia and Schizoaffective Disorder [Phase 4]
Phase 4 trial results evaluating high-dose olanzapine for schizophrenia and schizoaffective disorder have been completed, according to the u…
-
CLINICAL_TRIALS trial_result · 2007-01-05Clinical Trial Update: Association Between Schizophrenia and Cancer
This completed clinical trial studied the association between schizophrenia and cancer.
-
CLINICAL_TRIALS trial_result · 2006-12-08Clinical Trial Update: Reboxetine Adjuvant Therapy for the Treatment of Schizophrenia [Phase 1]
A Phase 1 clinical trial is evaluating Reboxetine as adjuvant therapy for schizophrenia; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2006-10-17Clinical Trial Update: Quetiapine Decreases Smoking in Patients With Chronic Schizophrenia [NA]
A clinical trial update indicates that quetiapine reduces smoking behavior in patients with chronic schizophrenia.
-
CLINICAL_TRIALS trial_result · 2006-10-12Clinical Trial Update: Niacin Flushing as Marker of Cannabis Effects on Arachidonic Acid Pathways in Schizophrenia
This completed trial evaluated whether niacin-induced flushing can serve as a biomarker for cannabis effects on arachidonic acid pathways in…
-
CLINICAL_TRIALS trial_result · 2006-09-11Clinical Trial Update: A Comparative Study of New Medications for Psychosis in Adolescents [NA]
This clinical trial update reports the completion of a comparative study evaluating new medications for psychosis in adolescents. The study …
-
CLINICAL_TRIALS trial_result · 2006-08-04Clinical Trial Update: Depakote ER Plus an Atypical Antipsychotic Vs. an Atypical Antipsychotic Alone in the Treatment of Schizophrenia [Phase 2]
A Phase 2 trial by Abbott evaluated adding Depakote ER to an atypical antipsychotic versus an atypical antipsychotic alone for schizophrenia…
-
CLINICAL_TRIALS trial_result · 2006-07-25Clinical Trial Update: A First In Human Study Of PF-00184562 In Healthy Volunteers [Phase 1]
Pfizer completed a first-in-human Phase 1 study of PF-00184562 in healthy volunteers to evaluate safety, tolerability and pharmacokinetics, …
-
CLINICAL_TRIALS trial_result · 2006-07-20Clinical Trial Update: A Combination of Two Currently Approved Drugs to Enhance the Treatment of Schizophrenia [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial from Eli Lilly evaluating a combination of two approved drugs to enhance treatment of schizophrenia.
-
CLINICAL_TRIALS trial_result · 2006-07-19Clinical Trial Update: Olanzapine Versus An Active Comparator in the Treatment of Schizophrenia [Phase 4]
Phase 4 trial comparing olanzapine to an active comparator in schizophrenia has completed, evaluating efficacy and safety outcomes. The tria…
-
CLINICAL_TRIALS trial_result · 2006-07-19Clinical Trial Update: Pharmacokinetic Characterization of Intramuscular Olanzapine Depot [Phase 1]
Phase 1 clinical trial update characterizing the pharmacokinetics of intramuscular olanzapine depot (olanzapine pamoate) in schizophrenia an…